PeerVoice Endocrinology & Metabolic Disorders Audio PeerVoice

Visit https://www.peervoice.com/QKR860 to view the entire programme with slides. After completing “Fatos Pinar Topsever, MD / Jennifer Green, MD - CGA - Identify and Intervene: Optimising Care Pathways for Chronic Kidney Disease in Patients With Type 2 Diabetes”, participants will be able to: Use recommended screening tests to identify chronic kidney disease (CKD) in patients with type 2 diabetes mellitus (T2DM); Evaluate current efficacy and safety evidence guiding the use of novel treatments for CKD in T2DM; and Apply best practices for the initiation and management of novel therapies for treatment of CKD and T2DM.

Visit https://www.peervoice.com/BSG860 to view the entire programme with slides. After completing “George Kassianos, CBE, MD (Hons), FRCGP / Gili Regev-Yochay, MD - Current 2024 COVID-19 Vaccination Campaign: The Evidence Supporting the Call to Action”, participants will be able to: Summarise the evidence supporting the need for the current 2024 COVID-19 vaccination campaign for older adults and vulnerable individuals; and Outline the key recommendations by the World Health Organization (WHO) and European Centre for Disease Prevention and Control (ECDC) on the current 2024 COVID-19 vaccination roll-out.

Visit https://www.peervoice.com/HPE860 to view the entire programme with slides. After completing “Carel le Roux, MD, PhD - Prioritising Obesity Care in Our Clinical Practices: Why We Must and How We Can”, participants will be able to: Apply best practices for the screening and formal diagnosis of obesity as a chronic disease; Identify patients who would benefit from treatment or referral for management of obesity; and Evaluate current and emerging strategies for treating obesity as a chronic disease.

Visit https://www.peervoice.com/TBP860 to view the entire programme with slides. After completing “Meena B. Bansal, MD, FAASLD - The Many Faces of MASH: Recognising Risk, Improving Identification, and Maximising Management in the Primary Care Setting”, participants will be able to: Discuss the pathogenesis and metabolic drivers of metabolic dysfunction-associated steatohepatitis (MASH); Apply risk stratification scores for liver fibrosis; and Develop guideline-recommended management plans for patients with MASH.

Visit https://www.peervoice.com/SCT860 to view the entire programme with slides. After completing “Andreea Ciudin, MD, PhD - Adjusting Our Mindset and Our Approach: Patient and Provider Perspectives on the Modernisation of Obesity Care”, participants will be able to: Explain the rationale for screening for and formally diagnosing obesity as a chronic disease; Apply best practices for communication with people who have obesity about the associated risks and treatment options; and Apply a multidisciplinary, multispeciality approach to obesity care.

Visit https://www.peervoice.com/MPR860 to view the entire programme with slides. After completing “Lise Lotte Gluud, MD - Following the Evidence-Based Road: Improving Care for MASH Through Use of Clinical Care Pathways in Primary Care”, participants will be able to: Apply strategies to identify patients who warrant additional screening for metabolic dysfunction-associated steatohepatitis (MASH) based on clinical suspicion and imaging; Discuss serum biomarkers and non-invasive screening techniques for fibrosis; and Describe guideline-recommended strategies for the management of comorbidities in patients with MASH.